SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-069052
Filing Date
2021-12-10
Accepted
2021-12-10 16:33:55
Documents
1
Period of Report
2021-12-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4588
  Complete submission text file 0001209191-21-069052.txt   5950
Mailing Address 100 BINNEY STREET CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET CAMBRIDGE MA 02142 617-949-5200
TCR2 THERAPEUTICS INC. (Issuer) CIK: 0001750019 (see all company filings)

IRS No.: 474152751 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address TCR2 THERAPEUTICS INC. 100 BINNEY STREET, SUITE 710 CAMBRIDGE MA 02142
Business Address
Olagunju Peter (Reporting) CIK: 0001875057 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38811 | Film No.: 211485822